Admission to Trading

Summary by AI BETAClose X

St. James's Place plc has announced the admission to trading of 7,500 ordinary shares of 15 pence each, issued under employee share schemes on June 18, 2026. These shares are fully fungible with existing ordinary shares and were admitted to the Main Market of the London Stock Exchange under a block admission dated March 18, 2021. Following this issuance, the total number of securities in issue as of July 1, 2026, stands at 517,495,853.

Disclaimer*

St. James's Place PLC
01 July 2026
 

St. James's Place plc ('SJP' or the 'Company')

Notification of Admission to Trading (PRM 1.6.4R)

SJP announces today the following information in accordance with The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R.

1

Details of Issuer

a)

Name

St. James's Place plc

b)

LEI

213800M993ICXOMBCP87

2

Details of the transferable securities admitted to trading

a)

Name, type and identification code

St. James's Place plc - ordinary shares of 15 pence

 

ISIN: GB0007669376

 

b)

Regulated market

London Stock Exchange - Main Market

c)

Number of further securities issued and admitted

7,500

d)

Total number of securities in issue following admission

517,495,853 as at 1 July 2026

e)

Fungibility

Fully fungible with existing Ordinary Shares

3

Admission details

a)

Date of admission

Issued on 18 June 2026 (admitted under a block admission dated 18 March 2021)

b)

Prospectus information

Prospectus: N/A

Supplementary: N/A

Company's webpage: https://www.sjp.co.uk

c)

Coverage of notification

Issue of shares under the Company's employee share schemes on 18 June 2026, admitted to trading on the Main Market of the London Stock Exchange under the Company's existing block admission of shares dated 18 March 2021.

 

For further information please contact:

 

Jonathan Dale

Company Secretary

St. James's Place plc (LEI: 213800M993ICXOMBCP87)

Tel: +44 (0)1285 717237

1 July 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings